ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,308.15
1.17%
US Tech 100
18,100.40
1.48%
Dow Jones
39,908.00
0.88%
Brent Oil
82.725
0.21%
Bitcoin
65,821.45
6.95%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Pulmonx Corporation (LUNG) Quote

Pulmonx Corporation

Pulmonx Corporation (LUNG)

NASDAQ
9.32
0.41
(4.60%)
At close: May 15 4:00PM
Delayed by 15 minutes
9.32
0.41
( 4.60% )
After Hours: 4:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
9.32
Bid
7.07
Ask
14.91
Volume
262,399
8.80 Day's Range 9.35
7.11 52 Week Range 14.92
Market Cap
359.168M
Previous Close
8.91
Open
9.02
Last Trade
200
@
9.32
(formt)
Last Trade Time
16:00:06
Financial Volume
$ 2,411,226
VWAP
9.1892
Average Volume (3m)
646,114
Shares Outstanding
38,537,356
Dividend Yield
-
PE Ratio
-5.90
Earnings Per Share (EPS)
-1.58
Revenue
68.68M
Net Profit
-60.84M

About Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment ... Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.pulmonx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Pulmonx Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUNG. The last closing price for Pulmonx was $8.91. Over the last year, Pulmonx shares have traded in a share price range of $ 7.11 to $ 14.92.

Pulmonx currently has 38,537,356 shares outstanding. The market capitalization of Pulmonx is $359.17 million. Pulmonx has a price to earnings ratio (PE ratio) of -5.90.

LUNG Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

May 07 2024
Edgar (US Regulatory)

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

May 06 2024
GlobeNewswire Inc.

Pulmonx Reports First Quarter 2024 Financial Results

REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...

May 01 2024
GlobeNewswire Inc.

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

REDWOOD CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that...

April 10 2024
GlobeNewswire Inc.

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...

April 02 2024
GlobeNewswire Inc.

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today...

March 15 2024
GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

March 07 2024
Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

March 07 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.01-0.107181136129.339.498.284855388.75174163CS
41.8725.10067114097.4510.017.115060868.41650735CS
12-5.08-35.277777777814.414.537.116461149.1152205CS
26-1.62-14.808043875710.9414.927.1145910510.31770176CS
52-3.72-28.52760736213.0414.927.1133921610.66738019CS
156-28-75.02679528437.3245.814.0741235518.42730844CS
260-28.68-75.47368421053869.47794.0739254422.46678331CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

Discussion

View Full Feed
gawti88 gawti88 4 minutes ago
LOL i love shorters!!! haha
CEOS
ACE13 ACE13 4 minutes ago
They just filed for an extension of 5 trading days from the 15th.
LVVV
Eli's Gone Eli's Gone 4 minutes ago
GL...
Singhania Singhania 4 minutes ago
$BSEM Reports Huge Jump In Revenue And Gross Margin
Revenue: Increased to $41.9 million in Q1 2024 from $600,000 in Q1 2023.
Gross Margin: Rose to 95% in Q1 2024 from 82% in Q1 2023.
Net Income: Reported positive for the first time on a US GAAP basis.
https://finance.yah
BSEM
1hot toddy 1hot toddy 4 minutes ago
CEO COMPANY SAYS WORTH BILLIONS THAT WHAT WE WANT. $$$$$$$$$$$$$$$$$$$$$$
IGPK
CAN11 CAN11 4 minutes ago
absolute failure .0001 for years.
PSRU
Mark Mark 4 minutes ago
$GWAV over .07 again in A/Hs
GWAV
CAN11 CAN11 4 minutes ago
more meaningless news.
PSRU
Bizreader Bizreader 5 minutes ago
Yeah super cool.

I'm going through all my paperwork here and I see 2 green ballots and one yellow pack for each of the securities and now I remember that I photocopied them, filled them out, and sent them in. This way I could prove whether or not I actually received them.
COOP
BADALI BADALI 5 minutes ago
How is your chart telling here. If you sold then you lost money here
CBDD
CAN11 CAN11 5 minutes ago
What success? Complete failure.
PSRU
Shev11 Shev11 5 minutes ago
If we're all wondering about form C

By submitting a Form C, filers are claiming that they are planning to raise money through a crowdfunding campaign and are exempt from registering their business’s securities with the SEC. Form C filers do not have the same obligations for submitting
SSOF
Singhania Singhania 5 minutes ago
$BSEM blows away estimates
$BSEM looks interesting; they blew away estimates, revenue increased to 41.9 million. You heard it here first https://finance.yahoo.com/news/biostem-technologies-inc-bsem-q1-070914107.html
BSEM
al44 al44 5 minutes ago
Indoctrination vs education =

https://i.imgur.com/z4FfwiG.png
highlandernew highlandernew 5 minutes ago
🔴🔴Citadel COKEHEADS night shift STARTED on AMC?:

Their great "leader" needs to transfer more offshore... for HIMSELF.

https://investorshub.advfn.com/uimage/uploads/2024/5/15/mhrukAMC_COKEHEADS_AH.png
https
AMC
LTListener LTListener 5 minutes ago
Yeah, I think I read that about the CX- in my DD review. I have not seen anything similar for KRM-II-81, not to say that it wont have any issues in human clinicals, but I think it is similar enough to current treatments only with much less deficiency in performance.

To me the most
RSPI
dstep dstep 5 minutes ago
Or simply time passing and getting closer to EOQ and IDE being filed.
RDGL
tw0122 tw0122 5 minutes ago
ASTS $2.99 + 23%
ASTS
Nextbigone Nextbigone 5 minutes ago
$MATH https://www.marketwatch.com/articles/hong-kong-crypto-bitcoin-3be92a76?mod=mw_quote_news
MATH
rbl100 rbl100 5 minutes ago
Actually plenty have come back. They died and were revived. Hundreds explained details of people, conversations, actions and places they should not have known while clinically dead. Tons of proof. Pam Reynolds was documented entirely in 1991. 21 grams is the weight of the soul documented scient
AMC
Jay_B Jay_B 5 minutes ago
Chaaaadddd... where's the fu**ing 3-31-24 quarterly report? For the love of all that's holy man. Wake up!!
SFLM
Nihil8 Nihil8 5 minutes ago
337 days in EM.
CNNA
Singhania Singhania 6 minutes ago
I’m watching $BSEM, regenerative medicine is hot, the stock is cheap compared to peer group companies, read their research report here $SINGT $FFIE $SLNA $REBN $TTOO
https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_05152024_BSEM_Sorensen.pdf
BSEM FFIE REBN
shermann7 shermann7 6 minutes ago
Deflation As Economy Comes To A Halt | Michael Pento - Liberty and Finance - VIDEO

https://www.youtube.com/watch?v=PASIvx7hs18

Shermann
123tom 123tom 6 minutes ago
Thank you. Very helpful.
AVXL

Your Recent History

NASDAQ
LUNG
Pulmonx
LSE
FQ86
Citi Fun 24
BTRX
BESTUSDT
Bitpanda Ecosystem Token
LSE
EZ85
Citi Fun 25
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved